Treatment of localized dermatoses with intralesional betamethasome dipropionate.
Intralesional administration of betamethasone dipropionate, 5 mg/ml, was a safe and effective method of treating resistant localized lesions of patients with steroid-responsive dermatoses. Following a single injection, three-quarters of the patients had a good to excellent response which was maintained for the eight-week follow-up period.